CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
RHHBYPhase 2

Fenebrutinib Phase 2 Est. Readout

Fenebrutinib
Q2 2027~Q
CT.gov
00%
Competitive Landscape

1 competitor in Relapsing Multiple Sclerosis

View Full Landscape
Drug Information

Target Indication

Relapsing Multiple Sclerosis

Clinical Trial

NCT07161258

Last updated: 2/19/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.